It’s a fact: Approximately 50% of pregnancies in the U.S. are unintended, despite the fact that 62% of women of reproductive age in the U.S. use contraceptives. These unplanned pregnancies could be due to dissatisfaction with a contraceptive product, lack of understanding of its correct use, or the inability to access an appropriate option.
Because of the side effects, adverse events, or lack of spontaneity that can be associated with available contraceptive methods, approximately 40% of women are not satisfied with their current contraceptive method.
New and improved contraceptives that are easy to use, safe, and with limited side effects would contribute to an individual’s control over the number and timing of childbearing.
To help resolve the problems in women’s health, Clinipace Worldwide has developed an informative eBook, “Trials in Women’s Health: 7 Best Practices to Drive Time and Cost Savings for Your Contraceptive Clinical Trial,” which is now available for download here.
Read our eBook to learn more about the 7 best practices you can apply to a women’s contraceptive study to ensure better enrollment, compliance, and retention:
- Product type dictates study design and trial characteristics
- Time spent developing patient profile prior to trial start saves time later
- Regulatory requirements influence patient profile and need for monitoring
- Patient profile guides recruitment and potential retention issues
- Study protocol compliance ensures data quality
- Risk-based approach to monitoring applies systematic process that helps prevent or mitigate important and likely risks to data quality and participants
- Cloud-based eClinical platform addresses challenges with trial enrollment, compliance and retention
If you’re interested in more information about the challenges in women’s contraceptive clinical trials, click here to watch a recorded webcast.